Key facts
- It has raised $38.1M; the latest was Early Stage VC ($38.1M) in Sep 2025.
- Notable investors include Corstone Capital, NICE Investment Partners, Ryan Asset Management.
- Status: Privately Held (backing).
- ·The complete investor list — 3 names
- ·Watchlist + deal alerts for Dr. Bullet
- ·The full record, as it builds
Funding rounds
No funding rounds for Dr. Bullet are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Dr. Bullet
Operator of a comprehensive wellness brand intended to offer functional food products and pills. The company offers a range of products for fitness, including dieting kits, fat-burning tablets, fat-reduction pills, and calorie-burning tea, enabling consumers to lose fat and stay healthy.
- Sector
- Consumer Products and Services (B2C)
- HQ
- Seoul, South Korea
- Founded
- 2024
- Employees
- 99
- Website
- doctorblet.com/
- Ownership
- Privately Held (backing)
Dr. Bullet doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Dr. Bullet shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Dr. Bullet in its N-PORT filings yet. We sweep new filings monthly.